1. Home
  2. JVA vs RGNT Comparison

JVA vs RGNT Comparison

Compare JVA & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.47

Market Cap

17.8M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.31

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JVA
RGNT
Founded
1971
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
20.4M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
RGNT
Price
$4.47
$3.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
232.1K
3.5K
Earning Date
03-16-2026
05-08-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.24
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$2.80
52 Week High
$5.62
$8.35

Technical Indicators

Market Signals
Indicator
JVA
RGNT
Relative Strength Index (RSI) 66.12 47.61
Support Level $4.02 $2.80
Resistance Level $4.78 $3.34
Average True Range (ATR) 0.24 0.18
MACD -0.01 0.10
Stochastic Oscillator 72.73 88.69

Price Performance

Historical Comparison
JVA
RGNT

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: